Loading company…
Sniper develops analytical medical instruments, including an automated PCR system.
Founded in 2018, Sniper is based in Suzhou, China, and develops analytical medical instruments. Its DQ24 PCR System is an integrated device with six fluorescence channels and experiments lasting less than two hours. In October 2024, it raised Series B+ funding led by HM Capital, with participation from Co-Win Ventures and Leading Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in